NCT07474558Phase 2Not yet recruiting
SCALp Cooling for pReventing aLopecia With nEw anTibody-drug Conjugates
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Not yet recruiting
- Declared phase
- Phase 2
- Sponsor
- Jules Bordet Institute
- Participants (registry)
- 102
- Start
- September 2026 (planned)
- Primary completion
- January 2030 (planned)
- Study completion
- September 2031 (planned)
- Last registry update
- August 2026
- Countries
- Belgium
Conditions studied: Advanced or Metastatic Solid Tumour, Antibody-Drug Conjugate, Alopecia
Interventions: scalp cooling, photographs via the Belle.AI app, Antibody-Drug Conjugates
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.